Lymphocyte GH-axis hormones in immunity

Cellular Immunology

Volumn 285, Issue 1-2, 2013, Pages 118-132

  Weigent, Douglas A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Growth hormone; Growth hormone releasing hormone; IGF 1; Lymphocytes

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN C;

HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOREGULATION; LYMPHOCYTE; NERVOUS SYSTEM; NEUROENDOCRINE SYSTEM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW;

GROWTH HORMONE; GROWTH HORMONE RELEASING HORMONE; IGF-1; LYMPHOCYTES;

ANIMALS; CATTLE; DOGS; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHOCYTES; MICE; NEUROSECRETORY SYSTEMS; RATS; RECEPTOR, IGF TYPE 1; RECEPTORS, SOMATOTROPIN;

EID: 84886840999     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.10.003     Document Type: Review

References (201)

1. Blalock J.E., Smith E.M. Conceptual development of the immune system as a sixth sense. Brain Behav Immun 2007, 21:23-33.
2. Weigent D.A., Blalock J.E. Associations between the neuroendocrine and immune systems. J. Leukoc. Biol. 1995, 58:137-150.
3. Blalock J.E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 1989, 69:1-32.
4. Eskandari F., Webster J.I., Sternberg E.M. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res. Ther. 2003, 5:251-265.
5. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 1998, 9:259-275.
6. Arzt E., Pereda M.P., Castro C.P., Pagotto U., Renner U., Stalla G.K. Pathophysiological role of the cytokine network in the anterior pituitary gland. Front. Neuroendocrinol. 1999, 20:71-95.
7. Gong F.-Y., Deng J.-Y., Shi Y.-F. Stimulatory effect of interleukin-1B on growth hormone gene expression and growth hormone release from rat GH3 cells. Neuroendocrinology 2005, 81:217-228.
8. Blalock J.E. The immune system as the sixth sense. J. Int. Med. 2005, 257:126-138.
9. Benveniste E.N. Cytokines: Influence on glial cell gene expression and function. Neuroimmunoendocrinology 1997, 31-75. Karger, Basel. J.E. Blalock (Ed.).
10. Weigent D.A. Immunoregulatory properties of growth hormone and prolactin. J. Pharmacol. Ther. 1996, 69:237-257.
11. Render C.L., Hull K.L., Harvey S. Neural expression of the pituitary GH gene. J. Endocrinol. 1995, 147:413-422.
12. Mol J.A., VanGardesen E., Seman P.J., Wolswinkel J., Rijinberk A., Rutterman G.R. Growth hormone mRNA in mammary gland tumours of dogs and cats. J. Clin. Invest. 1995, 95:2028-2034.
13. Ogilvie S., Buhl W.C., Olson J.A., Shiverick K.T. Identification of a novel family of growth hormone-related proteins secreted by rat placenta. Endocrinology 1990, 126:3271-3273.
14. Allen J.T., Bloor C.A., Kedia R.K., Knight R.A., Spiteri M.A. Expression of growth hormone-releasing factor, growth hormone, insulin-like growth factor-1 and its binding proteins in human lung. Neuropeptide 2000, 34:98-107.
15. Palmetshofer A., Zechner D., Luger T.A., Barta A. Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts. Mol. Cell. Endocrinol. 1995, 113:225-234.
16. Izadyar F.Z.J., Van Tol H., Colenbrander B., Bevers M.M. Messenger RNA expression and protein localization of growth hormone in bovine ovarian tissue and in cumulus oocyte complexes (COCs) during in vitro maturation. Mol. Reprod. Dev. 1999, 53:398-406.
17. Blalock J.E. Production of peptide hormones and neurotransmitters by the immune system. Chem. Immunol. 1992, 52:1-24.
18. Hiestand P.C., Mekler P., Nordmann R., Grieder A., Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc. Natl. Acad. Sci. USA 1986, 83:2599-2603.
19. Hattori N., Saito T., Yagyu T., Jiang B.-H., Kitagawa K., Inagaki C. GH, GH receptor, GH secretagogue receptor, and Ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrin. Metab. 2001, 86:4284-4291.
20. Costoya J.A., Vidal A., Garcia-Barros M., Arce V., Devesa J. Expression of the human growth hormone normal gene (hGH-N) in proliferating and differentiated HL-60 cells. Exp. Cell Res. 1996, 228:164-167.
21. Kooijman R., Gerlo S., Coppens A., Hooghe-Peters E.L. Growth hormone and prolactin expression in the immune system. Ann. N.Y. Acad. Sci. 2006, 917:534-540.
22. Weigent D.A. High molecular weight isoforms of growth hormone in cells of the immune system. Cell. Immunol. 2011, 271:44-52.
23. Weigent D.A. Growth hormone and insulin-like growth factor-1 production by cells of the immune system. Growth and Lactogenic Hormones 2002, 87-100. Elsevier Science B.V., Amsterdam. L. Matera, R. Rapaport (Eds.).
24. Weigent D.A., Baxter J.B., Wear W.E., Smith L.R., Bost K.L., Blalock J.E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 1988, 2:2812-2818.
25. Hattori N., Shimatsu A., Sugita M., Kumagai S., Imura H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem. Biophys. Res. Commun. 1990, 168:396-401.
26. Kao T.L., Harbour D.V., Meyer W.J. Immunoreactive growth hormone production by cultured lymphocytes. Ann. N.Y. Acad. Sci. 1992, 650:179-181.
27. Kao T.L., Supowit S.C., Thompson E.A., Meyer W.J. Immunoreactive growth hormone production by human lymphocyte cell lines. Cell. Mol. Neurobiol. 1992, 12:483-498.
28. Varma S., Sabharwal P., Sheridan J.F., Malarkey W.B. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J. Clin. Endocrinol. Metab. 1993, 76:49-53.
29. Guarcello V., Weigent D.A., Blalock J.E. Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats. Cell. Immunol. 1991, 136:291-302.
30. Baxter J.B., Blalock J.E., Weigent D.A. Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 1991, 129:1727-1734.
31. Hattori N., Shimormura K., Ishihara T., Moridera K., Hino M., Ikekubo K., Kurahachi H. Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH, but not affected by insulin-like growth factor-1. J. Clin. Endocrinol. Metab. 1993, 76:937-939.
32. Weigent D.A., Blalock J.E. Growth hormone and the immune system. Prog. NeuroEndocrinImmunol. 1990, 3:231-241.
33. Kao T.L., Meyer W.J. Inhibition of immunoreactive growth hormone secretion from lymphoid cell lines by dexamethasone. Life Sci. 1992, 51:1033-1039.
34. Malarkey W.B., Wang J., Cheney C., Glaser R., Nagaraja H. Human lymphocyte growth hormone stimulates interferon gamma production and is inhibited by cortisol and norepinephrine. J. Neuroimmunol. 2002, 123:180-187.
35. Delhase M., Vergani P., Malur A., Hooghe-Peters E.L., Hooghe R.J. The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur. J. Immunol. 1993, 23:951-955.
36. Weigent D.A., Blalock J.E. Effect of the administration of growth hormone-producing lymphocytes on weight gain and immune function in dwarf mice. Neuroimmunomodulation 1994, 1:50-58.
37. Kooijman R., Malur A., Van Buul-Offers S.C., Hooghe-Peters E.L. Growth hormone expression in murine bone marrow cells is independent of the pituitary transcription factor Pit-1. Endocrinology 1997, 138:3949-3955.
38. Lemaigre F.P., Lafontaine D.A., Courtois S.J., Durviaux S.M., Rousseau G.G. Sp1 can displace GHF-1 from its distal binding site and stimulate transcription from the growth hormone gene promoter. Mol. Cell. Biol. 1990, 10:1811-1814.
39. Weigent D.A. Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. Cell. Immunol. 2013, 282:9-16.
40. Weigent D.A., Vines C.R., Long J.C., Blalock J.E., Elton T.S. Characterization of the promoter-directing expression of growth hormone in a monocyte cell line. Neuroimmunomodulation 2000, 7:126-134.
41. Van Leeuwen I.S.L., Teske E., Van Garderen E., Mol J.A. Growth hormone gene expression in normal lymph nodes and lymphomas of the dog. Anticancer Res. 2000, 20:2371-2376.
42. Chen H.T., Schuler L.A., Schultz R.D. Growth hormone and Pit-1 expression in bovine fetal lymphoid cells. Domest. Anim. Endocrinol. 1997, 14:399-407.
43. Vines C.R., Weigent D.A. Identification of SP3 as a negative regulatory transcription factor in the monocyte expression of growth hormone. Endocrinology 2000, 141:938-946.
44. Weigent D.A., Blalock J.E. Lymphocytes and hypothalamic peptides. Growth Hormone Secretogues 1996, 359-377. Springer-Verlag, New York. B.B. Bercu, R.F. Walker (Eds.).
45. Weigent D.A., Blalock J.E. Immunoreactive growth hormone-releasing hormone in rat leukocytes. J. Neuroimmunol. 1990, 29:1-13.
46. Weigent D.A., Riley J.E., Galin F.S., LeBoeuf R.D., Blalock J.E. Detection of growth hormone and growth hormone-releasing hormone-related messenger RNA in rat leukocytes by the polymerase chain reaction. Proc. Soc. Exp. Biol. Med. 1991, 198:643-648.
47. Stephanou A., Knight R.A., Lightman S.L. Production of a growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes. Neuroendocrinology 1991, 53:627-633.
48. Khorram O., Garthwaite M., Golos T. The influence of aging and sex hormones on expression of growth hormone-releasing hormone in the human immune system. J. Clin. Endocrinol. Metab. 2001, 86:3157-3161.
49. Merimee T.J., Grant M.B., Broder C.M., Cavalli-Sforza L.L. Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects. J. Clin. Endocrinol. Metab. 1989, 69:978-984.
50. Geffner M.E., Bersch N., Lippe B.M., Rosenfeld R.G., Hintz R.L., Golde D.W. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I. J. Clin. Endocrinol. Metab. 1990, 71:464-469.
51. Clayton P.E., Day R.N., Silva C.M., Hellmann P., Day K.H., Thorner M.O. Growth hormone induces tyrosine phosphorylation but does not alter insulin-like growth factor-1 gene expression in human IM-9 lymphocytes. J. Mol. Endocrinol. 1994, 13:127-136.
52. Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr. Rev. 1997, 18:157-179.
53. Fournier T., Riches D.W., Winston B.W., Rose D.M., Young S.K., Nobel D.W., Lake F.R., Henson P.M. Divergence in macrophage insulin-like growth factor-1 (IGF-I) synthesis induced by TNF-α and prostaglandin E2. J. Immunol. 1995, 155:2123-2133.
54. Wynes M., Riches D. Induction of macrophage insulin-like growth factor-1 expression by the Th2 cytokines IL-4 and IL-13. J. Immunol. 2003, 171:3550-3559.
55. Weigent D.A., Baxter J.B., Blalock J.E. The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav. Immun. 1992, 6:365-376.
56. Palmer J.M., Wallis M. Human growth hormone stimulates somatomedin C/insulin-like growth factor I production by the human lymphoid cell line, IM-9. Mol. Cell. Endocrinol. 1989, 63:167-173.
57. Kirstein M., Aston C., Hintz R., Vlassara H. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J. Clin. Invest. 1992, 90:439-446.
58. Arkins S., Rebeiz N., Brunke-Reese D.L., Biragyn A., Kelly K.W. Interferon gamma inhibits macrophage insulin-like growth facator-I synthesis at the transcriptional level. Mol. Endocrinol. 1995, 9:350-360.
59. Arkins S., Rebeiz N., Biragyn A., Reese D.L., Kelley K.W. Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 1993, 133:2334-2343.
60. Nyman T., Pekonen F. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol. 1993, 128:168-172.
61. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 1991, 5:3-18.
62. Baxter R.C., Dai J. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 1994, 134:848-852.
63. Neely E.K., Smith S.D., Rosenfeld R.G. Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4. Acta Endocrinol. 1991, 124:707-714.
64. Li Y.M., Arkins S., McCusker R.H., Donovan S.M., Liu Q., Jayaraman S., Dantzer R. Macrophages synthesize and secrete a 25kDa protein that binds insulin-like growth factor-1. J. Immunol. 1996, 156:64-72.
65. Gala R.R. Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 1991, 198:513-527.
66. Weigent D.A., Blalock J.E. Growth hormone and the immune system during health and disease. Curr. Opin. Eur. Med. 2002, 3:40-67.
67. Herington A.C., Lobie P.E. Signal transduction mechanisms underlying growth hormone receptor action. Open Endocrinol. J. 2012, 6:13-21.
68. Herrington J., Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol. Metab. 2001, 12:252-257.
69. Flores-Morales A., Greenhalgh C.J., Norstedt G., Rico-Bautista E. Negative regulation of growth hormone receptor signalling. Mol. Endocrinol. 2006, 20:241-253.
70. Xu J., Messina J.L. Crosstalk between growth hormone and insulin signalling. Vitam. Horm. 2009, 80:125-153.
71. Huang Y., Kim S.O., Yang N., Jiang J., Frank S.J. Physical and functional interaction of growth hormone and IGF-1 signalling elements. Mol. Endocrinol. 2004, 18:1471-1485.
72. Conway-Campbell B.L., Wooh J.W., Brooks A.J., Gordon D., Brown R.J., Lichanska A.M., Chin H.S., Barton C.L., Boyle G.M., Parsons P.G. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. Proc. Natl. Acad. Sci. USA 2007, 104:13331-13336.
73. Graichen R., Sandstedt J., Goh E.L.K., Isaksson O.G.P., Tornell J., Lobie P.E. The growth hormone-binding protein is a location-dependent cytokine receptor transcriptional enhancer. J. Biol. Chem. 2003, 278:6346-6354.
74. Frank S.J., Fuchs S.Y. Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system. Biochim. Biophys. Acta 2008, 1782:785-794.
75. Cowan J.W., Wang X., Guan R., He K., Jiang J., Baumann G., Black R., Wolfe M., Frank S. Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. J. Biol. Chem. 2005, 280:19331-19342.
76. Gagnerault M.-C., Postel-Vinay R.-C., Dardenne M. Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytoflurometry. Endocrinology 1996, 137:1719-1726.
77. de Mell0-Coelho V., Gagnerault M.-C., Souberbielle J.-C., Strasburger C.J., Savino W., Dardenne M., Postel-Vinay M.-C. Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 1998, 139:3837-3842.
78. Kiess W., Butenandt O. Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization. J. Clin. Endocrinol. Metab. 1985, 60:740-746.
79. Mertani H.C., Delehaye-Zervas M.C., Martini J.F., Postel-Vinay M.C., Morel G. Localization of growth hormone receptor messenger RNA in human tissues. Endocrine 1995, 3:135-142.
80. Badolato R., Bond H.M., Valerio G., Petrella A., Morrone G., Waters M.J., Venuta S., Tenore A. Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J. Clin. Endocrinol. Metab. 1994, 79:984-990.
81. Rapaport R., Sills I.N., Green L., Barrett P., Labus J., Skuza K.A., Chartoff A., Goode L., Stene M., Petersen B.H. Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels. J. Clin. Endocrinol. Metab. 1995, 80:2612-2619.
82. Dardenne M., Mello-Coelho V., Gagnerault M.C., Postel-Vinay M.C. Growth hormone receptors and immunocompetent cells. Ann. N.Y. Acad. Sci. 1998, 840:510-517.
83. Bresson J.-L., Jeay S., Gagnerault M.-C., Kayser C., Beressi N., Wu Z., Kinet S., Dardenne M., Postel-Vinay M.-C. Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein. Endocrine 1999, 140:3203-3209.
84. Derfalvi B., Szalai C., Mandi Y., Kiraly A., Falus A. Growth hormone receptor gene expression on human lymphocytic and monocytic cell lines. Cell Biol. Int. 1998, 22:849-853.
85. Ross R.J.M., Esposito N., Shen X.Y., VonLaue S., Chew S.L., Dobson P.R.M., Postel-Vinay M.-C., Finidori J. A short isoform of the human growth receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol. Endocrinol. 1997, 11:265-273.
86. Lobie P.E., Barnard R., Waters M.J. The nuclear growth hormone receptor/binding protein: antigenic and physiochemical characterization. J. Biol. Chem. 1991, 266:22645-22652.
87. Lincoln D.T., Sinowatz F., Temmim-Baker L., Baker H.I., Kolle S., Waters M.J. Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem. Cell Biol. 1998, 109:141-159.
88. Kiaris H., Schally A.V., Kalofoutis A. Extrapituitary effects of the growth hormone-releasing hormone. Vitam. Horm. 2005, 70:1-24.
89. Halmos G., Schally A.V., Czompoly T., Krupa M., Varga J.L., Rekasi Z. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. J. Clin. Endocinol. Metab. 2002, 87:4707-4714.
90. Busto R., Schally A.V., Varga J.L., Garcia-Fernandez M.O., Groot K., Armatis P., Szepeshazi K. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas. Proc. Natl. Acad. Sci. USA 2002, 99:11866-11871.
91. Garcia-Fernandez M.O., Schally A.V., Varga J.L., Groot K., Busto R. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines: the evaluation of signaling mechanisms in the stimulationo f cell proliferation. Breast Cancer Res. Treat. 2003, 77:15-26.
92. Halmos G., Schally A.V., Vargas J.L., Plonowski A., Rekasi Z., Czompoly T. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 2000, 97:10555-10560.
93. Abribat T., Boulanger L., Gaudreau P. Characterization of [25K-Tyr10] human growth hormone-releasing factor (1-44) amide binding to rat pituitary: evidence for high and low affinity classes of sites. Brain Res. 1990, 528:291-299.
94. Abribat T., Deslauriers N., Brazeau P., Gaudreau P. Alterations of pituitary growth hormone-releasing factors binding sites in aging rats. Endocrinology 1991, 128:633-635.
95. Boulanger L., Girard N., Strecko J., Gaudreau P. Characterization of a growth hormone-releasing hormone binding site in the rat renal medulla. Peptides 2002, 23:1187-1194.
96. Iguchi G., Okimura Y., Takahashi T., Mizuno I., Fumoto M., Takahashi Y., Kaji H., Abe H., Chihara K. Cloning and characterization of the 5'-flanking region of the human growth hormone-releasing hormone receptor gene. J. Biol. Chem. 1999, 274:12108-12114.
97. Weigent D.A. Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats. Cell. Immunol. 2013, 282:71-78.
98. Smith R.G., Jiang H., Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol. Metab. 2005, 16:436-442.
99. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard J.W., Taub D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine experssion by human monocytes and T cells. J. Clin. Invest. 2004, 114:57-66.
100. Poppi L., Dixit V.D., Baratta M., Giustina A., Tamanini C., Parvizi N. Growth hormone secretatogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes. Exp. Clin. Endocrinol. Diabetes 2002, 110:343-347.
101. Baserga R., Hongo A., Rubini M., Prisco M., Valentinis B. The IGF-1 receptor in cell growth, transformation, and apoptosis. Biochim. Biophys. Acta Rev. Cancer 1997, 1332:F105-F126.
102. Rosenfeld R., Thorsson A.V., Hintz R.L. Increased somatomedin receptor sites in newborn circulating human mononuclear cells. J. Clin. Endocrinol. Metab. 1979, 48:456.
103. Johnson E.W., Jones L.A., Kozak R.W. Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. J. Immunol. 1992, 148:63-71.
104. Kooijman R., Willems M., De Haas C.J., Rijkers G.T., Schuurmans A.G., Van Buul-Offers S.C., Heijnen C.J., Zegers B.J. Expression of type 1 insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrine 1992, 131:2244-2250.
105. Cross R.J., Elliott L.H., Morford L.A., Roszman T.L., McGillis J.P. Functional characterization of the insulin-like growth factor 1 receptor on Jurkat T cells. Cell. Immunol. 1995, 160:205-210.
106. Segretin M., Galeano A., Roldan A., Schillaci R. Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes. Horm. Res. 2003, 59:276-280.
107. Vincent A.M., Feldman E.L. Control of cell-survival by IGF signalling pathways. Growth Horm. IGF Res. 2002, 12:193-197.
108. O'Connor R. Regulation of IGF-1 receptor signaling in tumor cells. Horm. Metab. Res. 2003, 35:771-777.
109. Liu Q., Schacher D., Hurth C., Freund G.G., Dantzer R., Kelley K.W. Activation of phosphoatidylinositol 3'-kinase by insulin-like growth factor-1, rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J. Immunol. 1997, 159:829-837.
110. Tu W., Cheung P.-T., Lau Y.-L. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms. J. Immunol. 2000, 165:1331-1336.
111. Baserga R., Peruzzi F., Reiss K. The IGF-1 receptor in cancer biology. Int. J. Cancer 2003, 107:873-877.
112. Walsh P.T., O'Conner R. The insulin-like growth factor-1 receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur. J. Immunol. 2000, 30:1010-1018.
113. Kooijman R., Lauf J.J., Kappers A.C., Rijkers G. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. J. Exp. Med. 1995, 182:593-597.
114. Murphy L.J., Friesen H.G. Differential effects of estrogens and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 1988, 122:325-332.
115. Weigent D.A., Arnold R.E. Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone. Cell. Immunol. 2005, 234:54-66.
116. Arnold R.E., Weigent D.A. The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. J. Neuroimmunol. 2003, 134:82-94.
117. Arnold R.E., Weigent D.A. The inhibition of apoptosis in EL4 lymphoma cells overexpressing growth hormone. Neuroimmunomodulation 2004, 11:149-159.
118. Kelley K.W. The role of growth hormone in modulation of the immune response. Ann. N.Y. Acad. Sci. 1990, 594:95-103.
119. Meazza C., Pagani S., Travaglino P., Bozzolla M. Effect of growth hormone (GH) on the immune system. Pediatr. Endocrinol. Rev. 2004, (Suppl. 3):490-495.
120. Dardenne M., Smaniotto S., de Mello-Coelho M., Villa-Verde D.M., Savino W. Growth hormone modulates migration of developing T cells. Ann. N.Y. Acad. Sci. 2009, 1153:1-5.
121. Dialynas E., Brown-Borg H., Bartke A. Immune function in transgenic mice overexpressing growth hormone (GH) releasing hormone, GH or GH antagonist. Proc. Soc. Exp. Biol. Med. 1999, 22:178-183.
122. Goh E.L.K., Pircher T.J., Lobie P.E. Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis. Endocrine 1998, 139:4364-4372.
123. Berczi I. Pituitary hormones and immune function. Acta Paediatr. 1997, (Suppl. 423):70-75.
124. Schimpff R.M., Repellin A.M. Production of interleukin-1-alpha and interleukin-2 by mononuclear cells in healthy adults in relation to different experimental conditions and to the presence of growth hormone. Horm. Res. 1990, 33:171-176.
125. Kelley K.W. Growth hormone, lymphocytes and macrophages. [Review]. Biochem. Pharmacol. 1989, 38:705-713.
126. Fu Y.K., Arkins S., Fuh G., Cunningham B.C., Wells J.A., Fong S., Cronin M.J., Dantzer R., Kelley K.W. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J. Clin. Invest. 1992, 89:451-457.
127. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 2008, 252:91-110.
128. Zelazowski P., Dohler K.D., Stepien H., Pawlikowski M. Effect of growth hormone-releasing hormone on human peripheral blood leukocyte chemotaxis and migration in normal subjects. Neuroendocrinology 1989, 50:236-239.
129. Gala R.R., Shevach E.M. Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc. Soc. Exp. Biol. Med. 1993, 204:224-230.
130. Dorshkind K., Horseman N.D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocrinol. Rev. 2000, 21:292-312.
131. Li Y.M., Brunke D.L., Dantzer R., Kelley K.W. Pituitary epithelial cell implants reverse the accumulation of CD4-CD8- lymphocytes in thymus glands of aged rats. Endocrinology 1992, 130:2703-2709.
132. Nagy E., Berczi I., Friesen H.G. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol. 1983, 102:351-357.
133. Kelley K.W., Brief S., Westly H.J., Novakofski J., Bechtel P.J., Simon J., Walker E.B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA 1986, 83:5663-5667.
134. Kelley K.W., Dantzer R. Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation. Stress and Immunity 1991, 433-453. CRC Press, Boca Raton. N. Plotnikoff, A. Murgo, R. Faith, J. Wybran (Eds.).
135. Hinton P.S., Peterson C.A., Lo H.C., Yang H., McCarthy D., Ney D.M. Insulin-like growth factor-I enhances immune resonse in dexamethasone-treated or surgically stressed rats maintained with total parenteral nutrition. J. Parenter. Enteral Nutr. 1995, 19:444-452.
136. Kelley K.W., Weigent D.A., Kooijman R. Protein hormones and immunity. Brain Behav. Immun. 2007, 21:384-392.
137. Kiecolt-Glaser J.K., Marucha P.T., Malarkey W.B., Mercado A.M., Glaser R. Slowing of wound healing by psychological stress. Lancet 1995, 346:1194-1196.
138. Malarkey W.B., Wu H., Cacioppo J.T., Malarkey K.L., Poehlmann K.M., Glaser R., Kiecolt-Glaser J.K. Chronic stress down-regulates growth hormone gene expression in peripheral blood mononuclear cells of older adults. Endocrine 1996, 5:33-39.
139. Masternak M.M., Bartke A. Growth hormone, inflammation and aging. Pathobiol. Aging Age Relat. Dis. 2012, 2:17293-17298.
140. Kiess W., Malozowski S., Gelato M., Butenand O., Doerr H., Crisp B., Eisl E., Maluish A., Belohradsky B.H. Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. Clin. Immunol. Immunopathol. 1988, 48:85-94.
141. Abbassi V., Bellanti J.A. Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone. Pediatr. Res. 1985, 19:299-301.
142. Bozzola M., Valtorta A., Moretta A., Cisternino M., Biscaldi I., Schimpff R.M. In vitro and in vivo effect of growth hormone on cytotoxic activity. J. Pediatr. 1990, 117:596-599.
143. Rapaport R., Oleske J., Ahdieh H., Skuza K., Holland B.K., Passannante M.R., Denny T. Effects of human growth hormone on immune functions: in vitro studies on cells of normal and growth hormone-deficient children. Life Sci. 1987, 41:2319-2324.
144. Petersen B.H., Rapaport R., Henry D.P., Huseman C., Moore W.V. Effect of treatment with biosynthetic human growth hormone (GH) on peripheral blood lymphocyte populations and function in growth hormone-deficient children. J. Clin. Endocrinol. Metab. 1990, 70:1756-1760.
145. Spadoni G.L., Rossi P., Ragno W., Galli E., Cianfarani S., Galasso C., Boscherini B. Immune function in growth hormone-deficient chidren treated with biosynthetic growth hormone. Acta Paediatr. Scand. 1991, 80:75-79.
146. Lebl J., Sediva A., Snajderova M., Pruhova S., Rakosnikova V. Immune system in adults with childhood-onset growth hormone deficiency: effect of growth hormone therapy. Endocr. Regul. 2000, 34:169-173.
147. Rovensky J., Vigas M., Lokaj J., Cuncik P., Lukac P., Takac A. Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly. Endocrinol. Exp. (Bratisl) 1982, 16:129-134.
148. Kofzmann H., Koller M., Czerin S., Clodi M., Svoboda T., Riedl M., Boltz-Nitulescu G., Zielinkski C.C., Luger A. Effect of elevated growth hormone concentrations on the phenotype and functions of human lymphocytes and natural killer cells. Neuroendocrinology 1994, 60:618-625.
149. Wit J.M., Kooijman R., Rijkers G.T., Zegers B.J. Immunological findings in growth hormone-treated patients. Horm. Res. 1993, 39:107-110.
150. Argetsinger L.S., Carter-Su C. Mechanism of signaling by growth hormone receptor. Physiol. Rev. 1996, 76:1089-1107.
151. Kuhn-Velten W.N. Intracrinology and the local enzymatic control of hormone distribution and metabolism: dehydroepiandrosyerone does not just act as a prohormone for androgen and estrogens. Eur. J. Chem. Invest. 2000, 30:34-38.
152. Luu-The V., Labrie F. The intracrine sex steroid biosynthesis pathways. Prog. Brain Res. 2010, 181:177-192.
153. Gilmour R.S., Mitchell M.D. Nuclear lipid signaling: novel role of eicosanoids. Soc. Exp. Biol. Med. 2001, 226:1-4.
154. Re R. The intracrine hypothesis and intracellular peptide hormone action. Bioessays 2003, 25:401-409.
155. Dentice M., Marsili A., Zavacki A., Larsen P.R., Salvatore D. The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation. Biochim. Biophys. Acta 1830, 2013:3937-3945.
156. Iqbal J., Macdonald L.J., Low L., Seckl J.R., Yau C.W., Walker B.R., Hadoke W.F. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11B-HSDs to postangioplasty neointimal proliferation in mice. Endocrine 2012, 153:5896-5905.
157. Weigent D.A., Blalock J.E., LeBoeuf R.D. An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology 1991, 128:2053-2057.
158. Clevenger C.V., Altmann S.W., Prystowsky M.B. Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes. Science 1991, 253:77-79.
159. Werman A., Werman-Venkert R., White R., Lee J.K., Werman B., Krelin Y., Voronov E., Dinarello C.A., Apte R.N. The precursor form of IL-1-alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 2004, 101:2434-2439.
160. Farmer J.T., Weigent D.A. Expression of insulin-like growth factor-2 receptors on EL4 cells overexpressing growth hormone. Brain Behav. Immun. 2007, 21:79-85.
161. Farmer J.T., Weigent D.A. TGF-beta-1 expression in EL4 lymphoma cells overexpressing growth hormone. Cell. Immunol. 2006, 240:22-30.
162. Belletti B., Prisco M., Morrione A., Valentinis B., Navarro M., Baserga R. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase. J. Biol. Chem. 2001, 276:13867-13874.
163. Sugai M., Gonda H., Kusunoki T., Katakai T., Yokota Y., Shimizu A. Essential role of Id2 in negative regulation of IgE class switching. Nat. Immunol. 2003, 4:25-30.
164. Weigent D.A. Regulation of Id2 expression in EL4 T lymphoma cells overexpressing growth hormone. Cell. Immunol. 2009, 255:46-54.
165. Ruzinova M.B., Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell. Biol. 2003, 13:410.
166. Perry J.K., Emerald B.S., Mertani H.C., Lobie P.E. The oncogenic potential of growth hormone. Growth Horm. IGF Res. 2006, 16:277-289.
167. Kaulsay K.K., Mertani H.C., Tornell J., Morel G., Lee K.O., Lobie P.E. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp. Cell Res. 1999, 250:35-50.
168. Mukhina S., Mertani H.C., Guo K., Lee K.O., Gluckman P.D., Lobie P.E. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc. Natl. Acad. Sci. USA 2004, 101:15166-15171.
169. Niandong L., Hichem C., Mertani C.N.G., Tornell J., Lobie P.E. Mode of the autocrine/paracrine mechanism of growth hormone action. Exp. Cell Res. 1997, 237:196-206.
170. Xu X.Q., Emerald B.S., Goh E.L., Kannan N., Miller L.D., Gluckman P.D., Liu E.T., Lobie P.E. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. J. Biol. Chem. 2005, 280:23987-24003.
171. Calo V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 2003, 197:157-168.
172. Mohankumar K.M., Perry N., Kannan N., Kohno K., Gluckman P.D., Emerald B.S., Lobie P.E. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell. Endocrine 2008, 149:2219-2229.
173. Arnold R.E., Weigent D.A. The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone. Immunopharmacol. Immunotoxicol. 2003, 25:159-177.
174. Ardail D., Debon A., Perret-Vivancos C., Biol-N'Garaba M.-C., Krantic S., Lobie P.E., Morel G. Growth hormone internalization in mitochondria decreases respiratory chain activity. Neuroendocrinology 2010, 91:16-26.
175. Stepien T., Lawnicka H., Komorowski J., Stepien H., Siejka A. Growth hormone-releasing hormone stimulates the secretion of interleukin 17 from human peripheral blood mononuclear cells in vitro. NeuroEndocrinol. Lett. 2010, 31:852-856.
176. Sirani M.C., Annibale B., Tagliaferi F., Fais S., Deluca S., Pallone F., Delle Fave G., Aiuti F. Modulation of human natural killer activity by vasoactive intestinal polypeptide (VIP), glucagon, and GHRF specifically inhibit NK activity. Regul. Pept. 1992, 38:79-87.
177. Valtorta A., Maretta A., Maccario A., Bozzola M., Severi F. Influence of growth hormone-releasing hormone (GHRH) on phytohemagglutinin-induced lymphocyte activation: comparison of two synthetic forms. Thymuz 1991, 18:51-89.
178. Blazar B.R., Brennan C.A., Brozmeyer H.E., Schultz L.D., Vallera D.A. Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGHRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo. Exp. Hematol. 1995, 22:1397-1406.
179. Khorram O., Yeung N., Vu L., Yen S.S.C. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women. J. Clin. Endocrinol. Metab. 1997, 82:3590-3596.
180. MacLennan I.C., Gulbranson-Judge A., Toellner K.M., Casamayor-Palleja M., Chan E., Sze D.M., Luther S.A., Orbea H.A. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 1997, 156:53.
181. Schally A.V., Varga J.L., Engel J.B. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat. Endocrinol. Metab. 2013, 4:33-43.
182. Siejka A., Lawnicka H., Melen-Mucha G., Motylewska E., Komorowski J., Stepien H. Antineoplastic action of growth hormone-releasing hormone (GHRH) antagonists. Recent Pat. Anti-Cancer Drug Discov. 2012, 7:1-8.
183. Ikushima H., Kanaoka M., Kojima S. Requirement for growth hormone-releasing hormone in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2003, 171:2769-2772.
184. Kiaris H., Chatzistamou I., Papavassiliou A.G., Schally A.V. Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol. Metab. 2011, 8:311-317.
185. Korbonits M., Goldstone A.P., Gueorguiev M., Grossman A.B. Ghrelin-a hormone with multiple functions. Front. Neuroendocrinol. 2004, 25:27-68.
186. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
187. DeVriese C., Gregoire F., DeNeef P., Robberecht P., Delporte C. Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology 2005, 146:1514-1522.
188. Koo G.C., Huang C., Camacho R., Trainor C., Blake J.T., Sirotina-Meisher A., Schleim K.D., Wu T.-S., Cheng K., Nargund R., McKissick G. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 2001, 166:4195-4201.
189. Theil M.-M., Miyake S., Mizuno M., Tomi C., Croxford J.L., Hosoda H., Theil J., von Horsten S., Yokote H., Chiba A., Lin Y., Oki S., Akamizu T., Kangawa K., Yamamura T. Suppression of experimental autoimmune encephalomyelitis by Ghrelin. J. Immunol. 2009, 183:2859-2866.
190. Tapson V.F., Boni-Schnetzler M., Pilch P.F., Center D.M., Berman J.S. Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J. Clin. Invest. 1988, 82:950-957.
191. Kooijman R., Coppens A., Hooghe-Peters E. IGF-1 stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase. Cell. Signal. 2003, 15:1091-1098.
192. Kooijman R., Coppens A., Hooghe-Peters E.L. Insulin-like growth factor-I inhibits spontaneous apoptosis in human granulocytes. Endocrinology 2002, 143:1206-1212.
193. Kooijman R., Coppens A. Insulin-like growth facator-1 stimulates IL-10 production in human T cells. J. Leukoc. Biol. 2004, 76:862-867.
194. Bernabei P., Bosticardo M., Losana G., Regis G., DiPaola F., DeAngelis S., Biovarelli M., Novelli F. IGF-1 down-regulates IFN-γR2 chain surface expression and desensitizes IFN-γ/STAT-1 signalling in human T lymphocytes. Blood 2003, 102:2933-2939.
195. McCubrey J.A., Steelman L.S., Mayo M.W., Algate P.A., Dellow R.A., Kaleko M. Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood 1991, 78:921-929.
196. Heemskerk V.H., Daemen M.A.R.C., Buurman W.A. Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev. 1999, 10:5-14.
197. Edwards C.K., Ghiasuddin S.M., Schepper J.M., Yunger L.M., Kelley K.W. A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. Science 1988, 239:769-771.
198. Funk P.E., Kincade P.W., Witte P.L. Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates. Blood 1994, 83:361-369.
199. Gibson L.F., Piktel D., Landreth K.S. Insulin-like growth factor-1 potentiates expansion of interleukin-7 dependent pro-B cells. Blood 1993, 82:3005-3011.
200. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor 1 receptor. Endocr. Rev. 1995, 16:143-163.
201. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:824-854.